A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme
Clinical trial NCT01115491 · COMPLETED
Trial details
- NCT number
- NCT01115491
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-07-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.